L3Harris Technologies (LHX) has rallied 6.4% in five days to $276.46 on an earnings report with record backlog, but the move sits inside a weekly downtrend and the 14-day RSI is 82.7, well into overbought territory. The balance of evidence for the next 2–6 weeks leans negative, with low conviction: one point of four. Strong results and relative strength against the market argue against a deeper slide, which is why the reading is not firmer.
Why it matters
The catalyst was the third-quarter report on October 29, 2026. Revenue was $6.06 billion, up 7% (9% organic), and net income reached $632 million, up 37%, according to the SEC EDGAR quarterly filing. The accompanying SEC EDGAR results release showed operating margin up 200 basis points to 13.0% and a record backlog of $53.2 billion. Orders were $19.3 billion, a book-to-bill ratio of 3.2 times. The October 22 board appointment of Kimberly Fields, CEO of ATI, is routine governance and does not explain any price move.
The market's response was to buy, and quickly. The stock is up 16.7% over a month and 6.4% over five days, while SPY fell 2.1% over the same five days. No sector ETF comparison is available, so the split is simple. The market was a headwind, and the gain belongs to the stock itself, with the earnings report the obvious driver. The rally looks less convincing in other respects. Shares slipped 0.9% today from a $278.96 close on November 2, and volume is running about 66% below its 20-day average. That is a pause with little participation. Over six months the stock is still down 11.9%, so the bounce is repairing damage rather than reversing it.
No debate articles are attached to this report, so the argument shows up in the numbers. The case for the stock is the backlog, the margin gain and a consensus of buy among 20 analysts. The case against is the chart: price is below its 40-week and 200-day averages (the latter at $304.12) and 27% under the 52-week high of $378.48. Year to date LHX is down 6.0% while SPY is up 10.5%.
On valuation, the mean price target of $334.4 sits 17.3% above the price. The spread is wide, from a low of $241 to a high of $443. The lowest analyst is below today's price and the highest is far above it, so the market is still arguing over how much of the backlog turns into earnings. Market capitalization is about $51.5 billion.
What the evidence says
On the long term, the thesis is weakened rather than broken. Price is below its 40-week average, the weekly trend is down, and the 200-day average is overhead at $304.12. Still, the stock is above its 10-week and 50-day averages, and the 52-week low of $233.63 is 18.3% below the current price. The phase is a sharp rebound inside a larger downtrend, driven by a strong earnings report.
For the next 2–6 weeks the balance of evidence leans negative, and conviction is low at 1 of 4. Two things drive that. A rally inside a weekly downtrend has reached overbought, with the RSI at 82.7, and such rallies tend to run out of buyers near overhead supply, here the $292.68 zone. Today's thin volume fits that picture. Only one of four conviction points is met, which is why this is a lean and not a firm reading.
The strongest case against it is relative strength. LHX leads the S&P 500 by 12.3% over 50 days, and the results were strong, with a 3.2 times book-to-bill that suggests revenue visibility for years. A stock with that record backlog does not usually give back a whole rebound quickly. This does not tip the balance because the lead is measured over only 50 days. Over 200 days LHX trails the market by 12.9%, and the weekly trend is still down. It is the main reason conviction is not higher.
Levels that matter
With the weekly trend down, the structure holds below $292.68, a swing zone where sellers have appeared on earlier rallies. The trend would end above $298.03, another swing zone. A weekly close above it would mean the rebound has taken out the area where sellers have repeatedly stepped in. Further overhead sit $300, $303.72 and $316.96.
The breakout level on the downside is a daily close below $275.00, a round number just under the current price. From there the first target is $270.65, but that is only 0.2 to 1 against a stop at $294.37, which is $292.68 plus a quarter of the 14-day ATR. The second target, the 50-day average at $250.33, gives 1.3 to 1. The math does not reach 3 to 1. It would need a much tighter stop or a deeper target, such as the $233.63 52-week low, to get anywhere near that.
What would change the picture
The rule is a weekly close above $298.03. That would put price above the swing zone capping the rebound and challenge the downtrend reading. The non-price fact that would most likely do it is evidence that the record $53.2 billion backlog is converting into faster revenue and margins in the next quarterly report, which would validate the multiple the market is paying and support the analyst targets.
What to watch
- Next earnings: January 28, 2027. The number that matters is organic revenue growth, set against the 9% just reported, and whether backlog keeps building.
- Sector: defense budget decisions and large contract awards across Aerospace & Defense tend to move LHX before its own news.
- Valuation: the stock trades 17.3% below the $334.4 mean target, within a $241 to $443 range, so the consensus is more optimistic than the chart.